Abstract
Suicide is a complex behavior involving multiple psychological and biological factors. However, multidimensional and transdiagnostic approaches, including behavioral and biological correlates to suicidal behavior, are currently lacking. In this study we examined the role of impulsive and aggressive traits as well as thyroid function and serum albumin levels in the emergence of suicidal behavior in patients with different psychiatric diagnoses. Sixty patients (30 males and 30 females) with various psychiatric diagnoses who attempted suicide recently and sixty age- and gender-matched non-suicidal healthy subjects were included in the study. Albumin and thyroid hormone levels on admission were recorded and Barratt Impulsiveness Scale-11 (BIS-11), Buss-Perry Aggression Questionnaire (BPAQ) were administered to all subjects. Patients who underwent a suicide attempt had higher BIS-11 and BPAQ scores and serum fT4 levels, while serum albumin and TSH were significantly higher in the non-suicidal group. According to univariate and multivariate regression analyses, high BIS-11, BPAQ scores and low TSH levels were significant independent predictors of recent suicidal behavior. Our findings indicate that there is a robust relationship between suicidal behavior, thyroid dysfunction and low serum albumin. High impulsive and aggressive traits may be involved this relationship.
Similar content being viewed by others
REFERENCES
Steelesmith, D.L., Fontanella, C.A., Campo, J.V., Bridge, J.A, Warren, K. L., and Root, E.D., Jama Netw. Open, 2019, vol. 2, no. 9, pp. e1910936.
Van Heeringen, K. and Mann, J.J., Lancet Psychiatry, 2014, vol. 1, no. 1, pp. 63–72.
Balcioglu, Y.H. and Kose, S., Psychiatry Clin. Psychopharmacol., 2018, vol. 28, no. 3, pp. 314–328.
Gokcay, H. and Balcioglu, Y., Psychiatry Behav. Sci., 2020, vol. 10, no. 4, pp. 206–215.
Mann, J.J. and Currier, D., Arch. Suicide Res., 2007, vol. 11, no. 1, pp. 3–16.
Bauer, M., Goetz, T., Glenn, T., and Whybrow, P. C., J. Neuroendocrinol., 2008, vol. 20, no. 10, pp. 1101–1114.
Eng, L. and Lam, L., Neoreviews, 2020, vol. 21, no. 1, pp. e30–e36.
Pompili, M., Gibiino, S., Innamorati, M., Serafini, G., Del Casale, A., De Risio, L., Palermo, M., Montebovi, F., Campi, S., De Luca, V., Sher, L., Tatarelli, R., Biondi, M., Duval, F., Serretti, A., and Girardi, P., Psychiatry Res., 2012, vol. 200, no. 2–3, pp. 389–394.
Jose, J., Nandeesha, H., Kattimani, S., Meiyappan, K., Sarkar, S., and Sivasankar, D., Clin. Chim. Acta, 2015, vol. 444, pp. 78–80.
Duval, F., Mokrani, M.C., Lopera, F. G., Diep, T.S., Rabia, H., and Fattah, S., Psychoneuroendocrinology, 2010, vol. 35, no. 7, pp. 1045–1054.
De Luca, R., Davis, P.J., Lin, H.Y., Gionfra, F., Percario, Z.A., Affabris, E., Pedersen, J.Z., Marchese, C., Trivedi, P., Anastasiadou, E., Negro, R., and Incerpi, S., Front. Cell Dev. Biol., 2021, vol. 8, p. 614030.
Bergmans, R. S., Kelly, K.M., and Mezuk, B., . Affect. Disord., 2019, vol. 245, pp. 1052–1060.
Soderstrom, H. and Forsman, A., J. Neural Transm., 2004, vol. 111, no. 6, pp. 739–744.
Evrensel, A., Ünsalver, B.Ö., and Özşahin, A., Noropsikiyatri Ars., 2016, vol. 53, no. 2, pp. 120–125.
Ritchie, R.F., Palomaki, G.E., Neveux, L.M., Navolotskaia, O., Ledue, T.B., and Craig, W.Y., J. Clin. Lab. Anal., 2002, vol. 16, no. 5, pp. 237–245.
Powanda, M.C. and Moyer, E.D., Inflammopharmacology, 2021, vol. 29, no. 3, pp. 897–901.
Mahendhar, R., Shahbaz, A., Riaz, M., Aninyei, M., Reich, D. M., and Sachmechi, I., Cureus, 2018, vol. 10, no. 7, pp. e2903.
Tabata, F., Wada, Y., Kawakami, S., and Miyaji, K., Antioxidants (Basel, Switzerland), vol. 10, no. 4, p. 503.
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., and Jia, Y., PLoS One, 2015, vol. 10, no. 10, p. e0138904.
Vargas, H.O., Nunes, S.O., Pizzo de Castro, M., Bortolasci, C.C., Sabbatini Barbosa, D., Kaminami Morimoto, H., Venugopal, K., Dodd, S., Maes, M., and Berk, M., J. Affect. Disord., 2013, vol. 150, no. 3, pp. 923–930.
Ambrus, L. and Westling, S., Nord. J. Psychiatry, 2019, vol. 73, no. 4–5, pp. 229–232.
Kim, M.K., Kwon, H.S., Baek, K. H., Lee, J.H., Park, W.C., Sohn, H. S., Lee, K.W., and Song, K.H., Diabetes Care, 2010, vol. 33, no. 12, pp. 2546–2548.
First, M.B., Structured clinical interview for the DSM (SCID), The Encyclopedia of Clinical Psychology, John Wiley & Sons, Ltd, 2015, pp. 1–6.
Elbir, M., Alp Topbas, O., Bayad, S., Kocabas, T., Topak, Z., Cetin, S., Sahabettin, C., Ozdel, O., Atesci, F.C., and Aydemir, O., Turk Psikiyatr. Derg., 2019, vol. 30, no. 1, pp. 51–56.
Güleç, H., Tamam, Lut., Güleç, M.Y., Turhan, M., Karakuş, Gonca., Zengin, M., and Stanford, M., Klin. Psikofarmakol. Bul., 2008, vol. 18, no. 4, pp. 251–258.
Patton, J.H., Stanford, M.S., and Barratt, E.S., J. Clin. Psychol., 1995, vol. 51, no. 6, pp. 768–774.
Demirtas-Madran, H., Turkish J. Psychiatry, 2012, vol. 24, no. 2, p. 124.
Buss, A.H. and Perry, M., J. Pers. Soc. Psychol., 1992, vol. 63, no. 3, pp. 452–459.
Duval, F., Mokrani, M.C., Erb, A., Gonzalez Opera, F., Calleja, C., and Paris, V., Psychoneuroendocrinology, 2017, vol. 85, pp. 100–109.
Peng, R., Dai, W., and Li, Y., Psychiatry Res., 2018, vol. 266, pp. 111–115.
Joffe, R.T. and Levitt, A.J., Can. J. Psychiatry, 2008, vol. 53, no. 12, pp. 833–838.
Dumais, A., Lesage, A.D., Alda, M., Rouleau, G., Dumont, M., Chawky, N., Roy, M., Mann, J.J., Benkelfat, C., and Turecki, G., Am. J. Psychiatry, 2005, vol. 162, no. 11, pp. 2116–2124.
Doihara, C., Kawanishi, C., Yamada, T., Sato, R., Hasegawa, H., Furuno, T., Nakagawa, M., and Hirayasu, Y., Psychiatry Clin. Neurosci., 2008, vol. 62, no. 3, pp. 352–354.
Gvion, Y., and Apter, A., Arch. Suicide Res., 2011, vol. 15, no. 2, pp. 93–112.
Sinai, C., Hirvikoski, T., Vansvik, E.D., Nordström, A.L., Linder, J., Nordström, P., and Jokinen, J., Psychoneuroendocrinology, 2009, vol. 34, no. 10, pp. 1526–1532.
Cleare, A.J., McGregor, A., Chambers, S.M., Dawling, S., and O’Keane, V., Neuroendocrinology, 1996, vol. 64, no. 1, pp. 65–69.
Sullo, A., Brizzi, G., and Maffulli, N., Can. J. Physiol. Pharmacol., 2003, vol. 81, no. 7, pp. 747–751.
Fujiwara, S.I. and Amisaki, T., Biochim. Biophys. Acta - Gen. Subj., 2013, vol. 1830, no. 12, pp. 5427–5434.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical approval. All procedures in the study involving human participants conformed to the 1964 Declaration of Helsinki or ethical standards. The study was approved by the Local Ethics Committee (IRB: 07/02/2020— 2020.02.1.13.018.r2.030).
Informed consent. Written informed consent was obtained from all participants and, if any, their legal representatives/guardians following a thorough explanation of the study procedure.
Additional information
Corresponding author; address: Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Department of Psychiatry, 34147, Istanbul, Turkey. e-mail: yhasanbalcioglu@gmail.com.
Rights and permissions
About this article
Cite this article
Hasan Gokcay, Balcioglu, Y.H. & Solmaz, M. The Role of Impulsive and Aggressive Traits, Albumin and Thyroid Functions in Recent Suicide Attempters: An Investigation with a Transdiagnostic Approach. Neurochem. J. 16, 491–497 (2022). https://doi.org/10.1134/S1819712422040079
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712422040079